Theriva Biologics, Inc. (TOVX)
0.2659
-0.03
(-9.89%)
USD |
NYAM |
May 19, 16:00
0.2554
-0.01
(-3.95%)
After-Hours: 20:00
Theriva Biologics EPS Diluted (Quarterly) : -0.0498 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.044M |
| Revenue (Quarterly) | 0.30M |
| Total Expenses (Quarterly) | 2.344M |
| Enterprise Value | 2.805M |
| Gross Profit Margin (Quarterly) | 92.00% |
| Profit Margin (Quarterly) | -681.3% |
| Earnings Yield | -952.4% |
| Normalized Earnings Yield | -601.13 |